Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Shifa Biomedical presents data on new PCSK9 inhibitor P-21

Nov. 15, 2018

Celgene patents GLP-1 receptor agonists

Nov. 14, 2018

KalVista designs enlarged phase II study for KVD-900 in HAE

Nov. 13, 2018

Small-molecule hepcidin production inhibitor developed for treatment of anemia of chronic disease

Nov. 12, 2018

Codexis announces topline results from phase Ia study of CDX-6114

Nov. 9, 2018

Study points to new bone building strategy

Nov. 9, 2018

DSMB recommends discontinuation of phase III study of PREOB for osteonecrosis

Nov. 7, 2018

Corcept Therapeutics enrolling participants in phase III study of relacorilant

Nov. 7, 2018

Fat and fibroblasts

Nov. 7, 2018

REWIND study of Trulicity meets primary efficacy objective

Nov. 6, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...